Truvada (tenofovir/emtricitabine)

DRUG2 trials

Sponsors

University of Cincinnati, Massachusetts General Hospital

Conditions

HIV InfectionsMultiple Sclerosis

Phase 2

Effects of Antiviral Therapies on Epstein-Barr Virus Replication

Enrolling by invitationNCT05957913

Massachusetts General HospitalMultiple Sclerosis

Start: 2023-06-05End: 2026-12-31Target: 50Updated: 2025-10-27

Phase 4

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

CompletedNCT00885664

University of CincinnatiHIV Infections

Start: 2005-10-31End: 2010-03-31Updated: 2022-08-10